Patrick James Orme

Array ( [id] => 6087896 [patent_doc_number] => 20110217299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'TARGETING PAX2 FOR THE TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 13/050604 [patent_app_country] => US [patent_app_date] => 2011-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 29178 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217299.pdf [firstpage_image] =>[orig_patent_app_number] => 13050604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8458052 [patent_doc_number] => 08293719 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'iRNA agents targeting VEGF' [patent_app_type] => utility [patent_app_number] => 13/043228 [patent_app_country] => US [patent_app_date] => 2011-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 74 [patent_no_of_words] => 51359 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13043228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8792769 [patent_doc_number] => 20130109738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'Control of Cardiac Growth, Differentiation and Hypertrophy' [patent_app_type] => utility [patent_app_number] => 13/580122 [patent_app_country] => US [patent_app_date] => 2011-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 22429 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13580122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048793 [patent_doc_number] => 20110207798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD FOR TREATING BREAST CANCER USING ADENINE NUCLEOTIDE TRANSLOCATOR 2 (ANT2) SIRNA OR ANT2 SHRNA' [patent_app_type] => utility [patent_app_number] => 13/030860 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 17085 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207798.pdf [firstpage_image] =>[orig_patent_app_number] => 13030860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6163511 [patent_doc_number] => 20110160291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'Oligonucleotide Compositions and Their Use to Induce Apoptosis' [patent_app_type] => utility [patent_app_number] => 13/021983 [patent_app_country] => US [patent_app_date] => 2011-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6266 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20110160291.pdf [firstpage_image] =>[orig_patent_app_number] => 13021983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487501 [patent_doc_number] => 20110236403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'TARGETING PAX2 FOR THE INDUCTION OF DEFB1-MEDIATED TUMOR IMMUNITY AND CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 13/010867 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45665 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236403.pdf [firstpage_image] =>[orig_patent_app_number] => 13010867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543401 [patent_doc_number] => 08318692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy' [patent_app_type] => utility [patent_app_number] => 13/005568 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 25 [patent_no_of_words] => 45716 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13005568 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496546 [patent_doc_number] => 20120295954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'TREATMENT OF INTERFERON REGULATORY FACTOR 8 (IRF8) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRF8' [patent_app_type] => utility [patent_app_number] => 13/519529 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23207 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13519529 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831894 [patent_doc_number] => 08940708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF' [patent_app_type] => utility [patent_app_number] => 13/518127 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9831894 [patent_doc_number] => 08940708 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-27 [patent_title] => 'Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF' [patent_app_type] => utility [patent_app_number] => 13/518127 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 26722 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585680 [patent_doc_number] => 20130004502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'INFLUENZA TARGETS' [patent_app_type] => utility [patent_app_number] => 13/518914 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 96 [patent_figures_cnt] => 96 [patent_no_of_words] => 16049 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6188933 [patent_doc_number] => 20110171730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'Conjugates For Use In Hepatocyte Free Uptake Assays' [patent_app_type] => utility [patent_app_number] => 12/974694 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25806 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171730.pdf [firstpage_image] =>[orig_patent_app_number] => 12974694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8815255 [patent_doc_number] => 20130116300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-09 [patent_title] => 'TREATMENT OF MEMBRANE BOUND TRANSCRIPTION FACTOR PEPTIDASE, SITE 1 (MBTPS1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO MBTPS1' [patent_app_type] => utility [patent_app_number] => 13/516097 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23077 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13516097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496403 [patent_doc_number] => 20120295811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'APTAMERS DIRECTED AGAINST THE MATRIX PROTEIN-1 OF TYPE A INFLUENZA VIRUSES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/511152 [patent_app_country] => US [patent_app_date] => 2010-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10744 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9273551 [patent_doc_number] => 08637483 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-28 [patent_title] => 'Antisense molecules and methods for treating pathologies' [patent_app_type] => utility [patent_app_number] => 13/509331 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 47 [patent_no_of_words] => 25159 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13509331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9233030 [patent_doc_number] => 08598334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-03 [patent_title] => 'HBV antisense inhibitors' [patent_app_type] => utility [patent_app_number] => 13/502370 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17693 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701556 [patent_doc_number] => 08394778 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-03-12 [patent_title] => 'Regulators of NFAT and/or store-operated calcium entry' [patent_app_type] => utility [patent_app_number] => 12/901195 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 73 [patent_figures_cnt] => 70 [patent_no_of_words] => 41811 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039519 [patent_doc_number] => 20110092568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'MODULATION OF MLCK-L EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/888947 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12783 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092568.pdf [firstpage_image] =>[orig_patent_app_number] => 12888947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8417716 [patent_doc_number] => 20120245216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROPATHIC PAIN' [patent_app_type] => utility [patent_app_number] => 13/393399 [patent_app_country] => US [patent_app_date] => 2010-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10701 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8621607 [patent_doc_number] => 08354521 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-15 [patent_title] => 'Compositions and methods for inhibiting adipogenesis by inhibition of constitutive coactivator of ppargamma' [patent_app_type] => utility [patent_app_number] => 12/870991 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11333 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12870991 [rel_patent_id] =>[rel_patent_doc_number] =>)